Fungal Research Trust
medical community awareness advocacy fungal diseases news

Media Centre


Coccidioidomycosis (Valley fever) missed as a cause of death in the USA

August 09 2017

About 150,000 annual cases of coccidioidomycosis occur each year in the USA (especially in Arizona), and at least as many in Central and South America, of which about ~40% are symptomatic and clinically apparent.
Read more

Call for global action on life-threatening fungal infections

August 01 2017

A ‘first of its kind’ series comprising of eight new authoritative papers has been published today in the prestigious journal The Lancet Infectious Diseases. The series gives new insights into the breadth of fungal diseases and a call to action for world health bodies to prevent millions of infections each year.
Read more

Two new species of thermally dimorphic yeast-like fungi has been described.

July 31 2017

Two new species, Emergomyces africanus from the newly created genus Emergomyces and Blastomyces percursus from the existing genus Blastomyces have recently been described.
Read more

Invasive mold infections in Thailand, Taiwan, India, China and Singapore

July 27 2017

Invasive mould infection (IMI) is a term for a large spectrum of emerging invasive diseases such as aspergillosis, zygomycosis, phaeohyphomycosis, or other mould infections. A recent study of the epidemiological and clinical characteristics of 155 IMI cases among Asian patients (Thailand, Taiwan, India, China and Singapore) has just been published by Dr Porpon Rotjanapan from Ramathibodi Hospital, Bangkok, Thailand and colleagues. In retrospective data from 2012 of 155 IMI cases found an incidence rate between 0.024 and 0.236 per 1,000 patient-days in hospital.
Read more

Major trial shows flucytosine a critical component of reducing deaths from cryptococcal meningitis

July 24 2017

At the International AIDS Society conference in Paris today, Sile Molloy from St George’s Hospital Medical School in London presented the ACTA study results: the largest ever study of cryptococcal meningitis. 678 evaluable patients from 9 sites in 4 African countries were randomized into an all oral regimen of fluconazole (1200mg/d) and flycytosine (100mg/d), amphotericin B deoxycholate (AmB) (1mg/Kg) for 7 or 14 days with either fluconazole or flucytosine.
Read more

 < 1 2 3 4 5 >  Last ›